Compare PHAR & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | ARRY |
|---|---|---|
| Founded | 1988 | 1989 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | PHAR | ARRY |
|---|---|---|
| Price | $17.20 | $8.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 20 |
| Target Price | ★ $38.00 | $10.38 |
| AVG Volume (30 Days) | 27.7K | ★ 5.6M |
| Earning Date | 11-06-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $362,274,000.00 | ★ $1,333,329,000.00 |
| Revenue This Year | $25.19 | $40.97 |
| Revenue Next Year | $4.47 | $13.09 |
| P/E Ratio | $2,989.65 | ★ N/A |
| Revenue Growth | 26.78 | ★ 35.75 |
| 52 Week Low | $7.50 | $3.76 |
| 52 Week High | $18.30 | $10.47 |
| Indicator | PHAR | ARRY |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 48.48 |
| Support Level | $16.55 | $8.94 |
| Resistance Level | $17.37 | $9.92 |
| Average True Range (ATR) | 0.68 | 0.57 |
| MACD | -0.09 | -0.08 |
| Stochastic Oscillator | 41.95 | 26.10 |
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.